94309-2
SARS-CoV-2 (COVID-19) RNA [Presence] in Specimen by NAA with probe detection
Active
Term Description
Qualitative detection of SARS coronavirus 2 (SARS-CoV-2) in various specimens, including lower & upper respiratory, serum, stool or urine, by nucleic acid amplification with probe-based detection. Results may be based on multiple assays to determine the presence of the virus in a specimen.
Source: Regenstrief LOINC
Part Description
LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.
The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus.
Source: LOINC
Reference Information
| Type | Source | Reference |
|---|---|---|
| Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
| Package Insert | Centers for Disease Control and Prevention | This document describes the use of real-time RT PCR (rRT-PCR) assays for the in vitro qualitative detection of 2019-Novel Coronavirus (2019-nCoV) in respiratory specimens and sera. The 2019-nCoV primer and probe sets are designed for the universal detection of SARS-like coronaviruses (N3 assay) and for specific detection of 2019-nCoV (N1 and N2 assays). Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus |
Fully-Specified Name
- Component
- SARS coronavirus 2 RNA
- Property
- PrThr
- Time
- Pt
- System
- XXX
- Scale
- Ord
- Method
- Probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RNA Spec Ql NAA+probe
- Display Name
- SARS-CoV-2 (COVID-19) RNA NAA+probe Ql (Specimen)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19), Specimen
Ask at Order Entry
81959-9 Public health laboratory ask at order entry panel
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
| LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
|---|---|---|---|---|
| 81959-9 | Public health laboratory ask at order entry panel | |||
| Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
| Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
| Indent86952-9 | Preliminary testing done Specimen | |||
| Indent86953-7 | Preliminary testing result Specimen | |||
| Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
| Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
| Indent95418-0 | Whether patient is employed in a healthcare setting | |||
| Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
| Indent11368-8 | Illness or injury onset date and time | C | ||
| Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
| Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
| Indent95421-4 | Whether patient resides in a congregate care setting | |||
| Indent82810-3 | Pregnancy status | C | ||
| Indent30525-0 | Age | a |
Example Answer List: LL3250-9
Source: Association of Public Health Laboratories| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Detected | LA11882-0 | ||
| Not detected | LA11883-8 | ||
| InconclusiveCopyright http://snomed.info/sct ID:419984006 Inconclusive (qualifier value) | LA9663-1 | ||
| Specimen unsatisfactory for evaluationCopyright http://snomed.info/sct ID:125154007 Specimen unsatisfactory for evaluation (finding) | LA13548-5 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 2296
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 94306-8 | SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
Member of these Groups Get Info
| LOINC Group | Group Name |
|---|---|
| LG51017-8 | SARSCoV2 detection |
| LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| de-AT | German (Austria) | Synonyms: SARS-CoV-2-RNA ql. /Material n. spez. PCR |
| de-DE | German (Germany) | SARS-Coronavirus 2 RNA: |
| es-ES | Spanish (Spain) | Panel del SARS-CoV-2 (COVID-19) RNA: |
| es-MX | Spanish (Mexico) | ARN del coronavirus 2 del SARS: |
| fr-FR | French (France) | Coronavirus SARS-CoV-2 ARN: |
| fr-CA | French (Canada) | coronavirus 2 du SRAS ARN: |
| it-IT | Italian (Italy) | SARS coronavirus 2 RNA: Synonyms: Coronavirus della SARS Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA |
| nl-NL | Dutch (Netherlands) | SARS-CoV-2 RNA: Synonyms: probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; |
| zh-CN | Chinese (China) | SARS 冠状病毒 2 RNA: Synonyms: 2019 新型冠状病毒; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=94309-2
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright